Abstract
The human genome and other genome sequencing projects have generated huge amounts of protein sequence information.Recently,a structural genomics project that aims to determine at least one representative three-dimensional structure from every protein family experimentally has been started.Homology modeling will play an essential role in structure based drug design such as in silico screening;because based on these representative structures the three-dimensional structures of the remaining proteins encoded in the various genomes can be predicted by homology modeling.The results of the last Critical Assessment of Techniques for Protein Structure Prediction (CASP5)demonstrated that the quality of homology modeling prediction has improved;reaching a level of reliability that biologists can now confidently use homology modeling.With improvements in modeling software and the growing number of known protein structures,homology modeling is becoming a more and more powerful and reliable tool.The present paper discusses the features and roles of homology modeling in structure based drug design, and describes the CHIMERA and FAMS modeling systems as examples.For a sample application,homology modeling of non-structural proteins of the severe acute respiratory syndrome (SARS)coronavirus is discussed. Many biological functions involve formation of protein-protein complexes;in which the protein molecules behave dynamically in the course of binding.Therefore,an understanding of protein-protein interaction will be very important for structure based drug design.To this end,normal mode analysis is useful.The present paper discusses the prediction of protein-protein interaction using normal mode analysis and examples of applications are given.
Keywords: protein structure prediction, homology modeling, structural genomics, structure based drug design, severe acute respiratory syndrome (sars), rna-dependent rna polymerase, normal mode analysis
Current Medicinal Chemistry
Title: Protein Structure Prediction in Structure Based Drug Design
Volume: 11 Issue: 5
Author(s): Mayuko Takeda-Shitaka, Daisuke Takaya, Chieko Chiba, Hirokazu Tanaka and Hideaki Umeyama
Affiliation:
Keywords: protein structure prediction, homology modeling, structural genomics, structure based drug design, severe acute respiratory syndrome (sars), rna-dependent rna polymerase, normal mode analysis
Abstract: The human genome and other genome sequencing projects have generated huge amounts of protein sequence information.Recently,a structural genomics project that aims to determine at least one representative three-dimensional structure from every protein family experimentally has been started.Homology modeling will play an essential role in structure based drug design such as in silico screening;because based on these representative structures the three-dimensional structures of the remaining proteins encoded in the various genomes can be predicted by homology modeling.The results of the last Critical Assessment of Techniques for Protein Structure Prediction (CASP5)demonstrated that the quality of homology modeling prediction has improved;reaching a level of reliability that biologists can now confidently use homology modeling.With improvements in modeling software and the growing number of known protein structures,homology modeling is becoming a more and more powerful and reliable tool.The present paper discusses the features and roles of homology modeling in structure based drug design, and describes the CHIMERA and FAMS modeling systems as examples.For a sample application,homology modeling of non-structural proteins of the severe acute respiratory syndrome (SARS)coronavirus is discussed. Many biological functions involve formation of protein-protein complexes;in which the protein molecules behave dynamically in the course of binding.Therefore,an understanding of protein-protein interaction will be very important for structure based drug design.To this end,normal mode analysis is useful.The present paper discusses the prediction of protein-protein interaction using normal mode analysis and examples of applications are given.
Export Options
About this article
Cite this article as:
Takeda-Shitaka Mayuko, Takaya Daisuke, Chiba Chieko, Tanaka Hirokazu and Umeyama Hideaki, Protein Structure Prediction in Structure Based Drug Design, Current Medicinal Chemistry 2004; 11 (5) . https://dx.doi.org/10.2174/0929867043455837
DOI https://dx.doi.org/10.2174/0929867043455837 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
8-Azapurine Nucleus: A Versatile Scaffold for Different Targets
Mini-Reviews in Medicinal Chemistry Biological Activities of Artemisinin Derivatives Beyond Malaria
Current Topics in Medicinal Chemistry Nucleosides with Modified Sugar Ring: Synthesis and Biological Activities
Current Organic Chemistry Lipotoxicity Disrupts Erythrocyte Function: A Perspective
Cardiovascular & Hematological Disorders-Drug Targets Drug Repurposing for Cancer Therapy in the Era of Precision Medicine
Current Molecular Pharmacology Ivermectin in COVID-19 Management: What is the Current Evidence?
Infectious Disorders - Drug Targets A Case of Multiple Sclerosis with Protracted Course of COVID-19
Infectious Disorders - Drug Targets Class- and Molecule-specific Differential Effects of Angiotensin II Type 1 Receptor Blockers
Current Pharmaceutical Design Selective Glucocorticoid Receptor Ligands
Medicinal Chemistry The Nature of Protein Domain Evolution: Shaping the Interaction Network
Current Genomics Evaluation of the Cytotoxic and Pro-Apoptotic Activities of Eu(III) Complexes with Appended DNA Intercalators in a Panel of Human Malignant Cell Lines
Medicinal Chemistry Antisense Oligonucleotide-Mediated Exon Skipping for Duchenne Muscular Dystrophy: Progress and Challenges
Current Gene Therapy Ongoing In Vivo Studies with Cytoskeletal Drugs in Tau Transgenic Mice
Current Alzheimer Research Lessons from Animal Culling during Human Pandemics: Is Vaccination a Viable Option for Animals?
Current Pediatric Reviews Development of Specific Radiopharmaceuticals for Infection Imaging by Targeting Infectious Micro-organisms
Current Pharmaceutical Design Chemistry and Biology of Chromatin Remodeling Agents: State of Art and Future Perspectives of HDAC Inhibitors
Current Medicinal Chemistry Emerging Therapeutic Approaches to COVID-19
Current Pharmaceutical Design Recent Progress in Structure Activity Relationship and Mechanistic Studies of Taxol Analogues
Mini-Reviews in Medicinal Chemistry Anti-obesity Agents: A Focused Review on the Structural Classification of Therapeutic Entities
Current Topics in Medicinal Chemistry Molecularly Imprinted Polymer and Computational Study of (E)-4-(2- cyano-3-(dimethylamino)acryloyl)benzoic Acid from Poly(ethylene terephthalate) Plastic Waste
Current Analytical Chemistry